RK

Rajeev Kumar

Active Director Director DIN 02161879
DIN 02161879 First appointment Jun 2008 Primary industry Energy and Power
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jun 2008
Shareholding value •••• Premium profile

About Rajeev Kumar

Data last updated:

Rajeev Kumar is a Director at Frizo India Private Limited (since 2008), Director at Nobelcure Healthcare Private Limited (since 2023) and Director at Frizo International Private Limited (since 2018). The companies operate in Energy and Power, Healthcare and Food and Beverages. The 3 current companies with reported revenue have a combined latest revenue of ₹26.77 Cr; the largest is Frizo India Private Limited at ₹21.72 Cr (FY 2023). Earlier, Rajeev Kumar was a Director at Jan Mangal Microdevelopment Federation (2022–2025) and Director at Akr Cotspin Private Limited (2018–2021).

DIN 02161879
Primary Designation Director
Industry Energy and Power
First Appointment 27 Jun 2008
Oldest Company Age 18 yrs
Largest company Frizo India Private Limited · ₹21.72 Cr (FY 2023)
Combined revenue ₹26.77 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Frizo India Private Limited U45309DL2008PTC345241
Director27 Jun 20082008₹21.72 Cr (FY 2023)Active
Nobelcure Healthcare Private Limited U85110RJ2022PTC081347
Director01 Jul 20232022₹3.60 Cr (FY 2025)Active
Frizo International Private Limited U55209RJ2018PTC062077
Director24 Aug 20182018₹1.45 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Mar 20222022Active
Akr Cotspin Private Limited U52100RJ2018PTC061737
Director05 Jul 20182018₹2.6 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Frizo India Private Limited
Frizo International Private Limited
Nobelcure Healthcare Private Limited
Jan Mangal Microdevelopment Federation
Premium access

Shareholding and investment profile for Rajeev Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Kumar

Rajeev Kumar currently holds 3 directorships: Frizo India Private Limited (Director, since 27 Jun 2008, revenue ₹21.72 Cr (FY 2023)); Nobelcure Healthcare Private Limited (Director, since 01 Jul 2023, revenue ₹3.60 Cr (FY 2025)); Frizo International Private Limited (Director, since 24 Aug 2018, revenue ₹1.45 Cr (FY 2025)).

Rajeev Kumar was first appointed on 27 Jun 2008 as Director at Frizo India Private Limited. The most recent appointment on record is 01 Jul 2023 at Nobelcure Healthcare Private Limited.

The 3 current companies of Rajeev Kumar that report revenue have a combined latest revenue of ₹26.77 Cr: Frizo India Private Limited ₹21.72 Cr (FY 2023); Nobelcure Healthcare Private Limited ₹3.60 Cr (FY 2025); Frizo International Private Limited ₹1.45 Cr (FY 2025).

Rajeev Kumar held 2 earlier board appointments: Jan Mangal Microdevelopment Federation (Director, 14 Mar 2022 to 15 Jan 2025); Akr Cotspin Private Limited (Director, 05 Jul 2018 to 08 Sep 2021).

The current boards of Rajeev Kumar's companies include Amul Gupta (Frizo India Private Limited), Gopal Krishan Gupta (Frizo India Private Limited), Gitika Arya Agrawal (Nobelcure Healthcare Private Limited), Vinod Kumar Agarwal (Nobelcure Healthcare Private Limited), Manish Gupta (Frizo International Private Limited), Sanjay Varshney (Frizo International Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available